Robert D. Kendig

698 total citations
15 papers, 574 citations indexed

About

Robert D. Kendig is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Robert D. Kendig has authored 15 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Robert D. Kendig's work include Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (4 papers) and RNA modifications and cancer (3 papers). Robert D. Kendig is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (4 papers) and RNA modifications and cancer (3 papers). Robert D. Kendig collaborates with scholars based in United States. Robert D. Kendig's co-authors include Kazushi Inoue, Dejan Maglic, Fumitake Kai, Pankaj Taneja, Sinan Zhu, Donna P. Frazier, Takayuki Sugiyama, Harshani R. Lawrence, Saı̈d M. Sebti and Yunting Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Robert D. Kendig

15 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert D. Kendig United States	12	326	276	91	58	57	15	574
Ying-Yi Li China	13	344 1.1×	263 1.0×	173 1.9×	33 0.6×	42 0.7×	30	624
Alexis de Haven Brandon United Kingdom	12	424 1.3×	179 0.6×	122 1.3×	81 1.4×	70 1.2×	22	595
Gretchen A. Repasky United States	8	403 1.2×	200 0.7×	95 1.0×	44 0.8×	47 0.8×	9	634
Ruth Ruddle United Kingdom	12	409 1.3×	137 0.5×	98 1.1×	79 1.4×	99 1.7×	23	652
Ma Xiaoling United States	3	586 1.8×	159 0.6×	101 1.1×	61 1.1×	39 0.7×	4	698
Víctor J. Sánchez‐Arévalo Lobo Spain	14	693 2.1×	311 1.1×	152 1.7×	44 0.8×	32 0.6×	23	887
Sunny Guin United States	16	349 1.1×	180 0.7×	112 1.2×	98 1.7×	29 0.5×	27	646
Jennifer M. Shipman United States	11	378 1.2×	128 0.5×	123 1.4×	51 0.9×	95 1.7×	13	539
Valter Croci Italy	6	295 0.9×	285 1.0×	85 0.9×	61 1.1×	31 0.5×	9	637
Maribelis Ruiz United States	10	469 1.4×	240 0.9×	150 1.6×	44 0.8×	20 0.4×	11	685

Countries citing papers authored by Robert D. Kendig

Since Specialization

Citations

This map shows the geographic impact of Robert D. Kendig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Kendig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Kendig more than expected).

Fields of papers citing papers by Robert D. Kendig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Kendig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Kendig. The network helps show where Robert D. Kendig may publish in the future.

Co-authorship network of co-authors of Robert D. Kendig

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. Kendig. A scholar is included among the top collaborators of Robert D. Kendig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. Kendig. Robert D. Kendig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kendig, Robert D., Fumitake Kai, Elizabeth A. Fry, & Kazushi Inoue. (2017). Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α. Cancer Investigation. 35(5). 301–312. 9 indexed citations

Frazier, Donna P., Robert D. Kendig, Fumitake Kai, et al.. (2012). Dmp1 Physically Interacts with p53 and Positively Regulates p53′s Stability, Nuclear Localization, and Function. Cancer Research. 72(7). 1740–1750. 34 indexed citations

Maglic, Dejan, Elizabeth A. Fry, Pankaj Taneja, et al.. (2012). Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer. Oncogene. 32(35). 4120–4129. 30 indexed citations

Lawrence, Harshani R., Mathew P. Martin, Yunting Luo, et al.. (2012). Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors. Journal of Medicinal Chemistry. 55(17). 7392–7416. 58 indexed citations

Taneja, Pankaj, et al.. (2011). Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes. Clinical Medicine Insights Oncology. 5. 235–57. 35 indexed citations

Maglic, Dejan, et al.. (2011). Abstract 3076: MEKK1 is a novel modulator of the Arf-p53 pathway via Dmp1 phosphorylation. Cancer Research. 71(8_Supplement). 3076–3076. 1 indexed citations

Taneja, Pankaj, Dejan Maglic, Fumitake Kai, et al.. (2010). Critical Roles of DMP1 in Human Epidermal Growth Factor Receptor 2/neu-Arf-p53 Signaling and Breast Cancer Development. Cancer Research. 70(22). 9084–9094. 33 indexed citations

Lawrence, Harshani R., Aslamuzzaman Kazi, Yunting Luo, et al.. (2010). Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors. Bioorganic & Medicinal Chemistry. 18(15). 5576–5592. 64 indexed citations

Taneja, Pankaj, Dejan Maglic, Fumitake Kai, et al.. (2010). Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clinical Medicine Insights Oncology. 4. 15–34. 125 indexed citations

10.

Taneja, Pankaj, Donna P. Frazier, Robert D. Kendig, et al.. (2009). MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer. Expert Review of Molecular Diagnostics. 9(5). 423–440. 56 indexed citations

11.

Mallakin, Ali, Takayuki Sugiyama, Fumitake Kai, et al.. (2009). The Arf‐inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin‐1, JunB and Egr1. International Journal of Cancer. 126(6). 1403–1416. 33 indexed citations

12.

Merkler, David J., Casey C. Cosner, Lamar Galloway, et al.. (2008). Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine α-hydroxylating monooxygenase (PHM). Bioorganic & Medicinal Chemistry. 16(23). 10061–10074. 10 indexed citations

13.

Sugiyama, Takayuki, Donna P. Frazier, Pankaj Taneja, et al.. (2008). Signal Transduction Involving the Dmp1 Transcription Factor and its Alteration in Human Cancer. SHILAP Revista de lepidopterología. 2. 209–19. 12 indexed citations

14.

Wahle, Joseph, et al.. (2007). Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell. The Journal of Immunology. 179(12). 8009–8015. 42 indexed citations

15.

Grier, Robert E., et al.. (1983). Autosomal dominant inheritance of the Aarskog syndrome. American Journal of Medical Genetics. 15(1). 39–46. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact